|
Á¶¼±»ì
|
|
 |
CplOOboPxBXAzeLFo |
 |
399 |
|
 |
What do you want to do when you've finished? http://9taxi.in.net 9taxi.com The class of drugs - known as glucagon-like-peptide-1(GLP-1) agonists and dipeptidylpeptidase-4 (DPP-4) inhibitors -includes Merck's $4 billion-a-year Januvia franchise,Novo Nordisk's Victoza, and Byetta and Onglyza fromBristol-Myers Squibb and AstraZeneca, amongothers. |
 |
 |
Randall |
 |
2019-05-31 22:08:50 |
|
|
|
|
|
|
|
|